|
|
Studies on Establishment of Co-expression System and Function of Human Complement Regulatory Proteins MCP and CD59 |
|
|
Abstract Recombinant expression vector pcDNA3-MCPCD59-DP containing human membrane complement regulatory proteins (hCRPs) MCP and CD59 cDNA was constructed successfully by using two independent promoters. After transfected into NIH3T3 cells with calcium phosphate-DNA precipitate method, NIH3T3 pcDNA3-MCPCD59-DP transfectants were obtained by G418 selection. Extraneous genes integration was identified by PCR. The co-expression of human CD59 and MCP at both mRNA and protein levels was confirmed by using RT-PCR and Western blot analysis. Human MCP and CD59 cDNA were integrated in NIH3T3 pcDNA3-MCPCD59-DP genomic DNA after continuous 30 times passages, indicating that NIH3T3 pcDNA3-MCPCD59-DP were stable cell lines. Human complement-mediated cytolysis assays showed that NIH3T3 cells transfected stably with pcDNA3-CD59, pcDNA3-MCP, and pcDNA3-MCPCD59-DP were protected from C-mediated damage and co-expressed human MCP and CD59 provided more excellent protection against C-mediated attack as compared with either CD59 or MCP expressed alone. These results suggest that the dicistronic vector represents an effective and efficacy strategy to overcome C-mediated damage and has potential therapeutic value for effectively controlling complement activation and finally for preventing hyperacute rejection in clinical gene therapy.
|
Received: 23 May 2006
Published: 25 September 2007
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|